Abstract

Spondyloarthritis (SpA) is an inflammatory rheumatic disease related to low bone mineral density. Because vitamin D plays an important role in bone metabolism and immune system modulation, the aim of this study was to evaluate the influence of polymorphisms in vitamin D receptor genes (VDR) in the development of SpA. In this case–control study, a total of 244 patients with SpA and 197 individuals with no SpA were included. Among the patients, 174 had ankylosing spondylitis (AS) and 66 had psoriatic arthritis (PsA). Genotyping of FokI (rs2228570 C > T), BsmI (rs1544410 C > T), ApaI (rs7975232 A > C), and TaqI (rs731236 T > C) was performed using PCR-RFLP, while genotyping of HLA-B∗27 was performed using PCR-SSP. Serum levels for hydroxy (OH) vitamin D and the clinical activity index of the disease (BASDAI) were also evaluated. SNPStats and OpenEpi software were used for statistical analysis. The ApaI a allele and ApaI a/a genotype were less frequent in PsA compared with controls. The ApaI a/a genotype was associated with a protecting factor for PsA in females, and ApaI A/a was associated with a protecting factor for the disease in HLA-B∗27 positive patients. Notwithstanding, the ApaI a/a genotype was a risk factor for SpA and AS in males. The FokI f/f genotype was associated with a better clinical activity in PsA. When considering the covariates, vitamin D sufficiency, and gender, the FokI F/F genotype was associated with a risk factor in males with SpA and AS compared with females with this same genotype. In conclusion, the ApaI rs7975232 polymorphism was associated with PsA, and the FokI rs2228570 polymorphism was associated with better clinical PsA activity. ApaI and FokI were associated with SpA and AS when considering gender and vitamin D sufficiency.

Highlights

  • Spondyloarthritis (SpA) is a term used for inflammatory diseases that are clinically, epidemiologically, and genetically related. ey comprise a group of chronic rheumatic diseases classified as ankylosing spondylitis (AS), psoriatic arthritis (PsA), and reactive arthritis (ReA) and SpA which is related to inflammatory bowel disease (IBD-SpA) and undifferentiated SpA [1, 2]. e prevalence of SpA in the world ranges from 0.20 to 1.61% [1]. e most distinct form of the disease is AS, which is characterized by inflammation followed by progressive ankylosis of the sacroiliac joints and spine with peripheral arthritis and enthesopathy

  • Because vitamin D is important in modulating the immune response and bone metabolism, the aim of this study was to evaluate a possible association between the polymorphisms in the vitamin D receptor gene (VDR), FokI, BsmI, ApaI, and TaqI, with SpA and its clinical forms. ese polymorphisms were correlated with the serum level of vitamin D and with the clinical activity index of the disease, Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)

  • E genotype frequency distributions for all polymorphisms evaluated were in Hardy-Weinberg equilibrium (P > 0.05), which means they are good representatives of the control group and ensure data quality. e genotype and allele frequency distributions of vitamin D receptor genes (VDR) were analyzed in patients and controls considering covariate genders (Tables 3–5) and gender plus vitamin D serum level (Table 6)

Read more

Summary

Introduction

Spondyloarthritis (SpA) is a term used for inflammatory diseases that are clinically, epidemiologically, and genetically related. ey comprise a group of chronic rheumatic diseases classified as ankylosing spondylitis (AS), psoriatic arthritis (PsA), and reactive arthritis (ReA) and SpA which is related to inflammatory bowel disease (IBD-SpA) and undifferentiated SpA (uSpA) [1, 2]. e prevalence of SpA in the world ranges from 0.20 to 1.61% [1]. e most distinct form of the disease is AS, which is characterized by inflammation followed by progressive ankylosis of the sacroiliac joints and spine with peripheral arthritis and enthesopathy. Is association explains the 20% attributed to the heredity of the disease [2] It International Journal of Inflammation does not completely explain the pathogenesis of the disease, when we consider that other genetic factors of susceptibility outside of the MHC have been uncovered. E gradual clinical worsening in the manifestations of SpA is linked to inflammation and low bone mineral density of the joints, due to a high production of inflammatory cytokines [12] and vitamin D deficiency [13]. VDR complex influences the regulation of about 3% of the human genome [14] It is a pleiotropic regulator of human physiology and modulates the immune system by suppressing the autoimmune process and tissue damage and delays chronic disease by inhibiting lymphocyte response via T helper 1 ( 1) and 17 [17, 18]. Vitamin D deficiency may be associated with both susceptibility and severity of SpA [15, 19, 20]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call